Uploaded June 2026 | Updated September 2026, 2 weeks ago
What if drug discovery could move from years of trial and error to weeks of virtual screening?
SandboxAQ CEO Jack Hidary joins CNBC’s Squawk on the Street to discuss SandboxAQ’s expanded partnership with NVIDIA, combining NVIDIA BioNeMo with AQState, SandboxAQ’s Large Quantitative Model, to help researchers identify promising drug candidates for GPCR targets.
It’s a step toward AI built for the physical world, where models trained on science and physics can help accelerate breakthroughs in medicine, materials, and beyond.
Learn more about SandboxAQ's LQMs here: sandboxaq.com
#sandboxaq #lqms
What if drug discovery could move from years of trial and error to weeks of virtual screening?
SandboxAQ CEO Jack Hidary joins CNBC’s Squawk on the Street to discuss SandboxAQ’s expanded partnership with NVIDIA, combining NVIDIA BioNeMo with AQState, SandboxAQ’s Large Quantitative Model, to help researchers identify promising drug candidates for GPCR targets.
It’s a step toward AI built for the physical world, where models trained on science and physics can help accelerate breakthroughs in medicine, materials, and beyond.
Learn more about SandboxAQ's LQMs here: sandboxaq.com
#sandboxaq #lqms
